Monday, August 15, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

WILMINGTON, Del. - Insiders at Incyte Corp., pharmaceuticals, dumped $12 million of their shares at "fraud-induced artificially inflated prices," a class action claims in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.